Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy CinCor Pharma stock (CinCor Pharma)

Buy CinCor Pharma stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

CinCor Pharma is a biotechnology business based in the US. CinCor Pharma shares (CINC) are listed on the NASDAQ and all prices are listed in US Dollars. CinCor Pharma employs 19 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy CinCor Pharma stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy CinCor Pharma stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – CINC. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy CinCor Pharma stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Moomoo
Finder Score: 4.3 / 5: ★★★★★
Exclusive
Moomoo
★★★★★
Stocks, Options, ETFs
$0
$0
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Public.com
Finder Score: 4.2 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
5.1%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

CinCor Pharma stock price (NASDAQ: CINC)

Use our graph to track the performance of CINC stocks over time.

CinCor Pharma shares at a glance

Information last updated 2024-06-30.
Latest market close$29.06
52-week range$0.00 - $0.00
50-day moving average $25.59
200-day moving average $25.14
Wall St. target price$41.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.01

Is it a good time to buy CinCor Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CinCor Pharma price performance over time

Historical closes compared with the close of $29.06 from 2023-03-03

1 week (2024-07-02) N/A
1 month (2024-06-09) N/A
3 months (2024-04-09) N/A
6 months (2024-01-09) N/A
1 year (2023-07-09) N/A
2 years (2022-07-13) 17.89%
3 years (2021-07-09) N/A
5 years (2019-07-09) N/A

CinCor Pharma financials

Gross profit TTM $0
Return on assets TTM -15.25%
Return on equity TTM -26.91%
Profit margin 0%
Book value $11.86
Market Capitalization $1.3 billion

TTM: trailing 12 months

CinCor Pharma share dividends

We're not expecting CinCor Pharma to pay a dividend over the next 12 months.

You may also wish to consider:

CinCor Pharma overview

CinCor Pharma, Inc. , a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. The company was incorporated in 2018 and is based in Waltham, Massachusetts. As of February 23, 2023, CinCor Pharma, Inc. operates as a subsidiary of AstraZeneca Finance and Holdings Inc. .

Frequently asked questions

What percentage of CinCor Pharma is owned by insiders or institutions?
Currently 11.999% of CinCor Pharma shares are held by insiders and 94.118% by institutions.
How many people work for CinCor Pharma?
Latest data suggests 19 work at CinCor Pharma.
When does the fiscal year end for CinCor Pharma?
CinCor Pharma's fiscal year ends in December.
Where is CinCor Pharma based?
CinCor Pharma's address is: City Point, Waltham, MA, United States, 02451
What is CinCor Pharma's ISIN number?
CinCor Pharma's international securities identification number is: US17240Y1091

More guides on Finder

Ask a Question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site